Cardiac cath team gets a new member. Defining a new sub-specialty: interventional echocardiography

Structural heart procedures are growing, and so is the cath lab team.

For two straight years, Diagnostic and Interventional Cardiology (DAIC) magazine has reported from the American Society of Echocardiography (ASE) Annual Scientific Sessions on the rise of a new sub-specialty—interventional echocardiography.

Interventional echocardiography crucial to structural heart

Structural heart procedures have seen rapid growth in the cath lab—and have been a featured topic at many of our 2016 regional educational conferences—and for all but the most expert interventionalists, echocardiography plays a big role in those cases.

Continue reading Cardiac cath team gets a new member. Defining a new sub-specialty: interventional echocardiography

Improving adherence to medications for heart failure: Medtronic says their CRT does it

Despite relatively few strong research studies supporting methodologies for improving adherence to medications for patients with heart failure, Medtronic's recent press release suggests their cardiac resynchronization therapy (CRT) implants might do the trick.

Medtronic accounced results of a retrospective analysis of administrative claims data of more than 4,500 patients with heart failure at the 2016 Heart Failure Society of America Scientific Meeting, Monday.

The analysis found that the number of patients "fully compliant" to a regimen of guideline-recommended medications "nearly doubled" at twelve months following CRT implants compared to those who did not receive implants.

Continue reading Improving adherence to medications for heart failure: Medtronic says their CRT does it

Future of cardiology: personalized care through genetics?

Genetic arrhythmia programs are paving new roads for personalized cardiac care—from preventing unnecessary cautionary testing or treatment to improving screening.

Melvin Scheinman, MD—the first person to perform catheter ablation for arrhythmia in a human patient, now chief of the Comprehensive Genetic Arrhythmia Program at the University of California, San Francisco—believes genetic testing will lead to the "ultimate form of personalized medicine," writes Gregory A. Freeman of HealthLeaders Magazine.

"If you examine the genetic background of a patient, you may be able to identify sensitivity to specific drugs, propensity for developing some very serious heart disorders, and at the same time rule out those same things for other people," said Scheinman to HealthLeaders.

"That is really what personalized medicine is all about—delivering the right care to the patient because you truly understand the patient and don't have to treat him or her as just a member of a group with certain statistical risks."

A proliferation of genetic arrhythmia programs "across the country" have been introducing new, measured responses to a sudden cardiac death in the family—preventive healthcare for some, but not all family members.

Continue reading Future of cardiology: personalized care through genetics?

Routine Cardiac Catheterization Expanding to Saturdays?

Expanding availability of elective, non-emergent cardiac catheterization services to Saturdays might significantly reduce length of stay, with no effect on clinical quality reports a recent economic impact study.

The study, published online in the American Journal of Managed Care found that reduced length of stay did not result in total cost savings, however.

In January 2009, Mayo Clinic Rochester expanded cardiac catheterization service availability (CSA) to Saturdays with the "goal of timely access with improved efficiency of care," write the authors.

Despite succeeding in greatly reducing length of stay—a statistically significant, adjusted average of 1.73 days—total costs of care were similar prior to CSA expansion.

Continue reading Routine Cardiac Catheterization Expanding to Saturdays?